Actuate Therapeutics Inc (ACTU)
EBITDA Growth
-13.10%
TTM · Period ending:
ACTU EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-13.10%period ending
Latest reported-13.10%period ending
ACTU TTM EBITDA YoY % (-8572.92% → -13.10%)
Year-over-year change
High-resolution chart · PNG
ACTU ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -13.1015% | |
| -14.8815% | |
| -7.2405% | |
| 15.7411% | |
| -23.1072% | |
| -131.9346% | |
| -8,572.9222% |